Access Pharmaceuticals Reports Significant Oral Bioavailability Of Cobalamin(TM) Oral Insulin In Additional Studies
March 12th, 2010 admin
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, which confirm earlier findings, were performed as part of on-going work with commercial collaborators that are evaluating Access’ Cobalamin™ Oral Drug Delivery Technology…
Related Videos from Youtube
Type I diabetes doesn't win!Click here to donate: walk.jdrf.org
The Diabetic Epidemic and What You...Natural health expert Dr. Joseph Mercola talks about preventing and reversing diabetes. To know more about diabetes, visit articles.mercola.com
Diabetes Basics: What Is Diabetes?Learn and know the difference between Type 1 and Type 2 diabetes, as well as what happens to the body when you have diabetes.
What is Diabetes?dLife's Nicole Johnson talks about the different types of diabetes.
Related Posts
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies…
Read More →
Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of alternative drug delivery systems, reported results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801. The randomized, double-blind, placebo-controlled, multi-centered study conducted in South Africa evaluated responses of 29 Type 2 diabetes...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced that the paper entitled, “Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects,” authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published...
Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) announced the signing of a contract with St. Michael’s Hospital, Toronto, Canada to conduct, “A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Three Doses of Oral Optina™ in Adult Subjects with Diabetic Macular...
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, announced the completion of a clinical study of Prelude…
Read More →
Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) announced the initiation of a Phase II clinical trial of Optina™ for the treatment of diabetic macular edema, an early stage of diabetic retinopathy. Diabetic macular edema is responsible for most vision loss in patients with diabetes mellitus…
Read More →
Fear of the needle is one of the main reasons many diabetics are reluctant to go on insulin, experts say, but two new delivery methods may relieve that fear.
Read More →
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced the completion of its’ pivotal Phase 2b clinical study of its oral insulin capsule, ORMD-0801. The Company expects to report results from this study within the coming weeks…
Read More →
Pharmaceutical company Novo Nordisk’s decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB) (a BMJ publication)…
Read More →
Cetero Research, the leading early-stage contract research organization (CRO), announced it has completed more than 500 diabetes research studies in the past three years for both Type 1 and Type 2 diabetics, including complex clamp studies and studies in Phase I, II, III and IV…
Read More →
Related Tweets from Twitter
|
sandroandrade09 (Sandro Andrade) : RT @oliberal: O chef paraense Paulo Martins,faleceu nesta madrugada,aos 64 anos de idade, devido a complicaes de diabetes. #drops.. Updated : 2010-09-09T13:01:01Z | Reply | View Tweet |
|
diabetesnc (DiabetesNsCuidamos) : Carambola e diabetes podem ser problema. O consumo da fruta pode at matar pacientes com insuficincia renal. http://ow.ly/2zQNG.. Updated : 2010-09-09T13:00:50Z | Reply | View Tweet |
|
Pretty_AP (Amy Perry) : I have when people pronounce "diabetes," "die-uh-beet-iss".. Updated : 2010-09-09T13:00:44Z | Reply | View Tweet |
|
Eanna_McKnight (Eanna McKnight) : Diabetes drug available on NHS months after experts call for... http://lnkd.in/ic5Aqk.. Updated : 2010-09-09T13:00:17Z | Reply | View Tweet |
|
mnt_diabetes (MNT Diabetes News) : Risk Of Gestational Diabetes, Cesarean Section, Reduced In The Obese By Bariatric Operations http://mnt.to/3Jss #diabetes.. Updated : 2010-09-09T13:00:10Z | Reply | View Tweet |
Related News from Digg
Leave a comment
| Trackback
